72 related articles for article (PubMed ID: 18949415)
1. Preclinical analysis of the antitumor efficacy of TS-1 using human uterine cervical cancer tumor xenografts.
Nagai N; Komatsu M; Yunokawa M; Shiroyama Y; Hirata E
Oncol Rep; 2008 Nov; 20(5):1149-56. PubMed ID: 18949415
[TBL] [Abstract][Full Text] [Related]
2. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
Nakata E; Fukushima M; Takai Y; Nemoto K; Ogawa Y; Nomiya T; Nakamura Y; Milas L; Yamada S
Oncol Rep; 2006 Sep; 16(3):465-71. PubMed ID: 16865244
[TBL] [Abstract][Full Text] [Related]
3. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
5. A potential important role for thymidylate synthetase inhibition on antitumor activity of fluoropyrimidine and raltitexed.
Kabeshima Y; Kubota T; Watanabe M; Saikawa Y; Nishibori H; Hasegawa H; Kitajima M
Anticancer Res; 2002; 22(6A):3245-52. PubMed ID: 12530071
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells.
Harada K; Kawaguchi S; Supriatno ; Onoue T; Yoshida H; Sato M
Oral Oncol; 2004 Aug; 40(7):713-9. PubMed ID: 15172641
[TBL] [Abstract][Full Text] [Related]
7. [Combined effect of S-1 and CDDP as a modulator for colon 26 liver metastasis].
Kitamura M; Arai K; Iwasaki Y; Takahashi T; Saitoh K; Fujii T; Shirasaka T
Gan To Kagaku Ryoho; 2000 Apr; 27(4):559-63. PubMed ID: 10790998
[TBL] [Abstract][Full Text] [Related]
8. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma.
Harada K; Ferdous T; Yoshida H
Oncol Rep; 2007 Nov; 18(5):1077-83. PubMed ID: 17914556
[TBL] [Abstract][Full Text] [Related]
9. Life prolonging effect of antitumor agents on postoperative adjuvant therapy in the lung spontaneous metastasis model in mice.
Shibata J; Murakami K; Abe M; Hashimoto A; Utsugi T; Fukushima M; Yamada Y
Anticancer Res; 1998; 18(2A):1203-9. PubMed ID: 9615789
[TBL] [Abstract][Full Text] [Related]
10. [Benefits of TS-1 plus leucovorin combination therapy for colorectal cancer: evaluation of therapeutic effect of TS-1 and leucovorin combination therapy using rodent model fed a low folate diet].
Tsujimoto H; Tsukioka S; Koizumi K; Nakagawa F; Uchida J; Sugimoto Y; Oka T; Fukushima M; Watanabe T
Gan To Kagaku Ryoho; 2007 Mar; 34(3):413-8. PubMed ID: 17353633
[TBL] [Abstract][Full Text] [Related]
11. An experimental study on the therapeutic effect of consecutive low-dose cisplatin with caffeine in sarcoma-bearing mice.
Takeda A; Tsuchiya H; Tajino T; Kikuchi S
Anticancer Res; 2005; 25(4):2777-84. PubMed ID: 16080526
[TBL] [Abstract][Full Text] [Related]
12. [An elderly patient with non-resectable lung cancer responding to TS-1].
Nakagawa K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1615-8. PubMed ID: 17108728
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of oral fluoropyrimidine derivative S-1 and radiation on human hypopharyngeal cancer xenografts.
Nakagawa T; Otsuki N; Masai Y; Sasaki R; Tsukuda M; Nibu K
Acta Otolaryngol; 2008 Aug; 128(8):936-40. PubMed ID: 18607998
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts.
Nagase H; Nakagawa F; Uchida J
Chemotherapy; 2018; 63(1):46-52. PubMed ID: 29393100
[TBL] [Abstract][Full Text] [Related]
15. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
Taniwaki S; Saruwatari A; Yoshida T; Mizoguchi A; Kitasato Y; Kitamura T; Hidaka A; Shiota K; Kuroda H; Tanaka M; Higashi T; Iwanaga Y; Ogata Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):279-82. PubMed ID: 19223745
[TBL] [Abstract][Full Text] [Related]
16. The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium.
Tsuda A; Fujiyama J; Miki A; Hori S; Ohtani H; Sawada Y
Cancer Chemother Pharmacol; 2008 Aug; 62(3):427-32. PubMed ID: 18026730
[TBL] [Abstract][Full Text] [Related]
17. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology.
Ako E; Ohira M; Yamashita Y; Kubo N; Muguruma K; Yashiro M; Sawada T; Nakata B; Kato Y; Hirakawa K
Hepatogastroenterology; 2008; 55(86-87):1939-42. PubMed ID: 19102427
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of hTR-siRNA adenovirus on human cervical cancer xenografts in nude mice].
Li WY; Li MY; Xiao LY; Zhang CL; Liu YR; Li XY; Zhang SY; Li Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):711-4, 731. PubMed ID: 19024296
[TBL] [Abstract][Full Text] [Related]
20. [Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
Nishikawa K; Iwase K; Fujii M; Matsuda C; Shimada K; Hirota M; Kimura T; Wada D; Nasu S; Tanaka Y
Gan To Kagaku Ryoho; 2009 Apr; 36(4):595-8. PubMed ID: 19381030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
